angiotensin ii has been researched along with quinapril in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 23 (48.94) | 18.2507 |
| 2000's | 22 (46.81) | 29.6817 |
| 2010's | 2 (4.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisher, ML; Gottlieb, SS; Krichten, CM; Robinson, S; Weir, MR | 1 |
| Major, TC; Panek, RL; Rapundalo, ST; Simmerman, J; Taylor, DG; Weishaar, RE | 1 |
| Ganten, D; Hellmann, T; Keuneke, C; Metzger, R; Peters, J; Yacullo, R | 1 |
| Weder, AB | 1 |
| Bobrowski, WF; Dominick, MA; Gough, AW; MacDonald, JR; Metz, AL | 1 |
| Brunner, HR; Nussberger, J; Pellacani, A | 1 |
| Jacobi, PC; Jurklies, B; Osswald, H; Zrenner, E | 1 |
| Briggs, JP; Lorenz, JN; Schnermann, J; Weihprecht, H | 1 |
| Bruneval, P; Domergue, V; Fornes, P; Giudicelli, JF; Richer, C; Vacher, E | 1 |
| Fritschka, E; Wolter, K | 1 |
| Leenen, FH; Ruzicka, M; Skarda, V | 1 |
| Bronsoms Artero, J; Matas Serra, M; Matè Benito, G; Mauri Nicolas, JM; Torguet Escuder, P; Vallès Prats, M | 1 |
| Bizollon, CA; Gharib, C; Lantelme, P; Lo, M; Mullins, JJ; Sassard, J | 1 |
| Jacobi, PC; Osswald, H; Zrenner, E | 1 |
| Endlich, K; Steinhausen, M | 1 |
| Hutri-Kähönen, N; Kähönen, M; Mäkynen, H; Pörsti, I; Tolvanen, JP; Wu, X | 1 |
| Benetos, A; Duriez, M; Lacolley, P; Levy, BI; Safar, ME; Taillard, F | 1 |
| Bustos, C; Egido, J; Hernández-Presa, MA; Lorenzo, O; Plaza, JJ; Ruiz-Ortega, M | 1 |
| Bastien, N; Lambert, C | 1 |
| Böhm, M; Buikema, H; Flesch, M; Paul, M; Pinto, YM; Teisman, AC; van Gilst, WH | 1 |
| Leenen, FH; Skarda, V; White, R; Yuan, B | 1 |
| Agirbasli, M; Brown, NJ; Vaughan, DE | 1 |
| Bastien, NR; Juneau, AV; Lambert, C; Ouellette, J | 1 |
| Anderson, TJ; Charbonneau, F; Elstein, E; Haber, H | 1 |
| Bavry, AA; Li, D; Mehta, JL; Phillips, MI; Zander, DS | 1 |
| Achard, JM; Aldigier, JC; Fournier, A; Leborgne, L; Tribouilloy, C | 1 |
| Leenen, FH; White, R; Yuan, B | 1 |
| Shimoni, Y | 1 |
| Doi, O; Ishikawa, J; Nawada, R; Obayashi, K; Sakata, K; Tamekiyo, H; Yoshida, H | 1 |
| Mann, DL | 1 |
| Barthelemy, C; Carayon, A; Cortines, M; Eurin, J; Lechat, P; Masson, F; Mougenot, N; Soualmia, H | 1 |
| Blanco, J; Egido, J; Esteban, V; Lorenzo, O; Mezzano, S; Ruiz-Ortega, M; Ruperez, M | 1 |
| Aoki, M; Higaki, J; Komai, N; Matsumoto, K; Moriguchi, A; Morishita, R; Nakamura, T; Ogihara, T; Tomita, N | 1 |
| Liu, XF; Shimoni, Y | 2 |
| Egido, J; Esteban, V; Lorenzo, O; Mezzano, S; Plaza, JJ; Ruiz-Ortega, M; Rupérez, M | 1 |
| Aizawa, Y; Kodama, M; Ma, M; Tachikawa, H; Takahashi, T; Watanabe, K; Wen, J; Yamaguchi, K | 1 |
| Buikema, H; Oosterga, M; van Geel, PP; van Gilst, WH; van Veldhuisen, DJ; Voors, AA | 1 |
| Barat, A; Bosch, RJ; Esbrit, P; Gazapo, R; González, L; Izquierdo, A; Ortega, A; Rámila, D | 1 |
| Yasuda, H | 1 |
| Arbolishvili, GN; Baklanova, NA; Belenkov, IuN; Mareev, VIu; Nasonova, SN; Skvortsov, AA; Sychev, AV | 1 |
| Baklanova, NA; Belenkov, IuN; Mareev, VIu; Masenko, VP; Nasonova, SN; Orlova, IaA; Skvortsov, AA; Sychev, AV | 1 |
| Egido, J; Ruiz-Ortega, M | 1 |
| Coletta, E; Leenen, FH; Ruzicka, M | 1 |
| Koller, A; Lotz, G; Racz, A; Veresh, Z | 1 |
| Coletta, E; Davies, R; Haddad, H; Leenen, FH; Ruzicka, M; White, R | 1 |
| Clancy, P; Golledge, J; Koblar, SA; Seto, SW | 1 |
3 review(s) available for angiotensin ii and quinapril
| Article | Year |
|---|---|
Renal protective effects of angiotensin converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Heart Rate; Hemodynamics; Humans; Hypertension; Isoquinolines; Kidney; Kidney Failure, Chronic; Kidney Tubules; Quinapril; Sodium; Tetrahydroisoquinolines | 1990 |
Effect of treatment on survival in an animal model of chronic heart failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cricetinae; Disease Models, Animal; Heart Failure; Humans; Isoquinolines; Quinapril; Renin-Angiotensin System; Tetrahydroisoquinolines | 1998 |
[Diabetic polyneuropathy and ACE gene polymorphism].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Clinical Trials as Topic; Diabetic Neuropathies; Humans; Indoles; Peptidyl-Dipeptidase A; Peripheral Nerves; Polymorphism, Genetic; Quinapril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrahydroisoquinolines | 2005 |
8 trial(s) available for angiotensin ii and quinapril
| Article | Year |
|---|---|
Quinapril ACE-inhibition effects on adrenergic parameters in moderate essential hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Catecholamines; Electrocardiography; Female; Hemodynamics; Humans; Hypertension; Isoquinolines; Male; Middle Aged; Muscle, Smooth, Vascular; Norepinephrine; Quinapril; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Tetrahydroisoquinolines | 1996 |
Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)
Topics: Aged; Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Drug Therapy, Combination; Enalapril; Endothelium, Vascular; Female; Humans; Isoquinolines; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines; Vasodilation | 2000 |
Effects of losartan and its combination with quinapril on the cardiac sympathetic nervous system and neurohormonal status in essential hypertension.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Therapy, Combination; Female; Heart; Hemodynamics; Humans; Hypertension; Isoquinolines; Losartan; Male; Middle Aged; Quinapril; Radionuclide Imaging; Radiopharmaceuticals; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Tetrahydroisoquinolines; Treatment Outcome | 2002 |
Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Bypass; DNA Transposable Elements; Double-Blind Method; Gene Deletion; Genotype; Humans; Mammary Arteries; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Quinapril; Tetrahydroisoquinolines; Vasoconstriction; Vasoconstrictor Agents | 2004 |
[Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect o
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Quinapril; Renin; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan | 2005 |
[Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADK
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiac Output, Low; Chronic Disease; Drug Therapy, Combination; Exercise Tolerance; Female; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Quinapril; Tetrahydroisoquinolines; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Remodeling | 2006 |
Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients?
Topics: Adult; Amlodipine; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Muscle, Skeletal; Norepinephrine; Quinapril; Renin; Sympathetic Nervous System; Tetrahydroisoquinolines | 2007 |
Effects of ACE inhibitors on cardiac angiotensin II and aldosterone in humans: "Relevance of lipophilicity and affinity for ACE".
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Aorta, Thoracic; Cardiac Catheterization; Coronary Sinus; Female; Humans; Hydrophobic and Hydrophilic Interactions; Hypertension; Lipids; Lisinopril; Male; Middle Aged; Perindopril; Prospective Studies; Pulmonary Wedge Pressure; Quinapril; Renin-Angiotensin System; Tetrahydroisoquinolines; Young Adult | 2010 |
36 other study(ies) available for angiotensin ii and quinapril
| Article | Year |
|---|---|
Determinants of the renal response to ACE inhibition in patients with congestive heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Female; Heart Failure; Humans; Isoquinolines; Kidney; Kidney Function Tests; Male; Middle Aged; Quinapril; Renal Circulation; Renin; Renin-Angiotensin System; Risk Factors; Tetrahydroisoquinolines | 1992 |
Evidence for a functional tissue renin-angiotensin system in the rat mesenteric vasculature and its involvement in regulating blood pressure.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Electric Stimulation; Isoquinolines; Mesentery; Peptidyl-Dipeptidase A; Quinapril; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Tetrahydroisoquinolines; Vasoconstriction | 1991 |
The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
Topics: Adrenal Glands; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Captopril; Enalapril; Gene Expression Regulation; Heart; Hydralazine; Hypertension; Isoquinolines; Kidney; Lisinopril; Male; Quinapril; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrahydroisoquinolines | 1990 |
Ultrastructural juxtaglomerular cell changes in normotensive rats treated with quinapril, an inhibitor of angiotensin-converting enzyme.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Hyperplasia; Hypertrophy; Isoquinolines; Juxtaglomerular Apparatus; Quinapril; Rats; Rats, Inbred Strains; Tetrahydroisoquinolines | 1990 |
Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cross Reactions; Humans; Immune Sera; Isoquinolines; Kinins; Male; Peptidyl-Dipeptidase A; Quinapril; Radioimmunoassay; Renin; Sensitivity and Specificity; Tetrahydroisoquinolines | 1994 |
Neuromodulatory effects of the renin-angiotensin system on the cat electroretinogram.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cats; Dark Adaptation; Dihydralazine; Electroretinography; Female; Isoquinolines; Male; Photic Stimulation; Quinapril; Renin-Angiotensin System; Retina; Tetrahydroisoquinolines | 1994 |
Synergistic effects of angiotensin and adenosine in the renal microvasculature.
Topics: Adenosine; Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Drug Synergism; In Vitro Techniques; Isoquinolines; Kidney; Male; Microcirculation; Muscle, Smooth, Vascular; Purinergic P1 Receptor Antagonists; Quinapril; Rabbits; Rats; Rats, Sprague-Dawley; Renal Circulation; Saralasin; Tetrahydroisoquinolines; Theophylline; Vasoconstriction | 1994 |
Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Height; Body Weight; Brain; Cerebrovascular Disorders; Diuresis; Heart Rate; Hypertension; Incidence; Isoquinolines; Kidney; Male; Myocardium; Proteinuria; Quinapril; Rats; Rats, Inbred SHR; Risk Factors; Tetrahydroisoquinolines; Time Factors | 1993 |
Pharmacokinetics and pharmacodynamics of quinaprilat after low dose quinapril in patients with terminal renal failure.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Humans; Isoquinolines; Kidney Failure, Chronic; Male; Middle Aged; Peptidyl-Dipeptidase A; Peritoneal Dialysis, Continuous Ambulatory; Quinapril; Renal Dialysis; Tetrahydroisoquinolines | 1993 |
Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Hypertrophy, Left Ventricular; Isoquinolines; Male; Myocardium; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines; Ventricular Pressure | 1995 |
Comparison between chronic converting enzyme inhibition and AT1 blockade in mRen2 transgenic rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Hypertension; Imidazoles; Isoquinolines; Losartan; Male; Natriuresis; Quinapril; Rats; Tetrahydroisoquinolines; Tetrazoles | 1996 |
Bradykinin receptor inhibition affects the rod b-wave in the cat electroretinogram.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cats; Electroretinography; Isoquinolines; Quinapril; Renin-Angiotensin System; Retinal Rod Photoreceptor Cells; Synaptic Transmission; Tetrahydroisoquinolines | 1996 |
Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Drug Synergism; Female; Isoquinolines; Kidney; Kinins; Quinapril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Renin-Angiotensin System; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan; Vasodilation | 1997 |
Arterial function in mineralocorticoid-NaCl hypertension: influence of angiotensin-converting enzyme inhibition.
Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension; Isoquinolines; Male; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Quinapril; Rats; Rats, Inbred WKY; Sodium Chloride; Tetrahydroisoquinolines | 1997 |
Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Bradykinin; Bradykinin Receptor Antagonists; Collagen; Drug Therapy, Combination; Hemodynamics; Hypertension; Hypertrophy; Imidazoles; Isoquinolines; Male; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Tetrahydroisoquinolines; Tetrazoles | 1997 |
Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis.
Topics: Administration, Oral; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Movement; Cells, Cultured; Chemokine CCL2; Down-Regulation; Glomerular Mesangium; Glomerulonephritis; Immune Complex Diseases; Isoquinolines; Kidney Glomerulus; Leukocytes, Mononuclear; NF-kappa B; Quinapril; Rats; Rats, Wistar; RNA, Messenger; Tetrahydroisoquinolines; Up-Regulation | 1998 |
Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Carbazoles; Carvedilol; Heart Function Tests; Hydralazine; Hypertension; Isoquinolines; Losartan; Norepinephrine; Propanolamines; Quinapril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrahydroisoquinolines | 1998 |
Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Heart Ventricles; Isoquinolines; Male; Myocardial Infarction; Myocardium; Nephrectomy; Quinapril; Rats; Rats, Wistar; Renin; Tetrahydroisoquinolines | 1999 |
Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Data Interpretation, Statistical; Diet, Sodium-Restricted; Female; Fibrinolysis; Heart Rate; Humans; Isoquinolines; Losartan; Male; Plasminogen Activator Inhibitor 1; Quinapril; Renin; Renin-Angiotensin System; Tetrahydroisoquinolines; Tissue Plasminogen Activator | 1999 |
Chronic AT1 receptor blockade and angiotensin-converting enzyme (ACE) inhibition in (CHF 146) cardiomyopathic hamsters: effects on cardiac hypertrophy and survival.
Topics: Alanine Transaminase; Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathy, Dilated; Creatinine; Cricetinae; Evaluation Studies as Topic; Isoquinolines; Losartan; Male; Mesocricetus; Myocardium; Potassium; Quinapril; Sodium; Tetrahydroisoquinolines | 1999 |
Inhibition of arterial thrombogenesis by quinapril but not losartan.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dose-Response Relationship, Drug; Isoquinolines; Losartan; Male; Platelet Aggregation; Quinapril; Rats; Rats, Sprague-Dawley; Superoxides; Tetrahydroisoquinolines; Thrombosis | 2000 |
Restenotic process and DD genotype after angiotensin-converting enzyme inhibitor treatment.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Genotype; Graft Occlusion, Vascular; Humans; Isoquinolines; Peptidyl-Dipeptidase A; Quinapril; Tetrahydroisoquinolines | 2001 |
Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system.
Topics: Adrenergic beta-Agonists; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Collagen; Coronary Circulation; Heart Rate; Isoproterenol; Isoquinolines; Losartan; Male; Myocardium; Organ Size; Peptidyl-Dipeptidase A; Quinapril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Tetrahydroisoquinolines | 2001 |
Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes.
Topics: Action Potentials; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Electric Conductivity; Isoquinolines; Mutation; Potassium Channels; Quinapril; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Angiotensin, Type 2; Receptors, Cell Surface; Receptors, Leptin; Saralasin; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan | 2001 |
Angiotensin II as an inflammatory mediator: evolving concepts in the role of the renin angiotensin system in the failing heart.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Heart Diseases; Inflammation Mediators; Isoquinolines; Quinapril; Rats; Renin-Angiotensin System; Tetrahydroisoquinolines | 2002 |
The mechanism of the angiotensin-converting enzyme inhibitor quinapril is not related to bradykinin level in heart tissue.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Isoquinolines; Kidney; Male; Myocardium; Peptidyl-Dipeptidase A; Quinapril; Radioimmunoassay; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Tetrahydroisoquinolines; Time Factors; Tissue Distribution | 2002 |
Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cells, Cultured; Chemokines; Cytokines; Disease Models, Animal; Female; Immune Complex Diseases; Inflammation Mediators; Infusion Pumps; Infusions, Parenteral; Kidney; Mesangial Cells; Nephritis; Quinapril; Rats; Rats, Wistar; RNA, Messenger; Tetrahydroisoquinolines; Tumor Necrosis Factor-alpha; Up-Regulation | 2002 |
Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive rats.
Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Endothelium, Vascular; Hepatocyte Growth Factor; Immunohistochemistry; Isoquinolines; Male; Muscle, Smooth; Proto-Oncogene Proteins c-met; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrahydroisoquinolines | 2003 |
Sex differences in the modulation of K+ currents in diabetic rat cardiac myocytes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Diabetes Mellitus, Experimental; Electric Stimulation; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Female; In Vitro Techniques; Male; Membrane Potentials; Myocytes, Cardiac; Ovariectomy; Patch-Clamp Techniques; Potassium Channels; Quinapril; Rats; Rats, Sprague-Dawley; Sex Characteristics; Tetrahydroisoquinolines | 2003 |
Angiotensin II increases connective tissue growth factor in the kidney.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Cells, Cultured; Connective Tissue Growth Factor; Female; Immediate-Early Proteins; Immune Complex Diseases; Immunohistochemistry; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Kidney; Nephritis; Quinapril; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydroisoquinolines; Up-Regulation; Vasoconstrictor Agents | 2003 |
Gender differences in ANG II levels and action on multiple K+ current modulation pathways in diabetic rats.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Action Potentials; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Electric Conductivity; Enzyme Inhibitors; Female; Genistein; Indoles; Male; Maleimides; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Protein Kinase C; Protein-Tyrosine Kinases; Quinapril; Rats; Rats, Sprague-Dawley; Sex Characteristics; Signal Transduction; Tetrahydroisoquinolines; Thionucleotides | 2004 |
Comparative effects of quinapril with enalapril in rats with heart failure.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomyopathy, Dilated; Collagen Type III; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Fibrosis; Male; Myocardium; Quinapril; Rats; Rats, Inbred Lew; RNA, Messenger; Survival Rate; Tetrahydroisoquinolines; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Function, Left; Ventricular Pressure | 2004 |
Role of the renin-angiotensin system on the parathyroid hormone-related protein overexpression induced by nephrotoxic acute renal failure in the rat.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Line; Enalapril; Folic Acid; Gentamicins; Kidney; Kidney Tubules; Losartan; Male; Parathyroid Hormone-Related Protein; Quinapril; Rats; Rats, Wistar; Receptor, Parathyroid Hormone, Type 1; Renin-Angiotensin System; Tetrahydroisoquinolines | 2005 |
Anti-inflammatory actions of quinapril.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Humans; Inflammation; Models, Biological; Quinapril; Tetrahydroisoquinolines | 2007 |
ADMA impairs nitric oxide-mediated arteriolar function due to increased superoxide production by angiotensin II-NAD(P)H oxidase pathway.
Topics: Acetophenones; Angiotensin II; Animals; Arginine; Arterioles; Enzyme Inhibitors; Losartan; Male; Muscle, Skeletal; NADPH Oxidases; Nitric Oxide; Oxidative Stress; Quinapril; Rats; Rats, Wistar; Signal Transduction; Superoxides; Tetrahydroisoquinolines; Vasoconstriction; Vasodilation | 2008 |
Role of the angiotensin converting enzyme 1/angiotensin II/angiotensin receptor 1 axis in interstitial collagenase expression in human carotid atheroma.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Carotid Artery Diseases; Collagenases; Dipeptides; Elastin; Endarterectomy, Carotid; Extracellular Matrix; Humans; Irbesartan; Matrix Metalloproteinase 1; Matrix Metalloproteinase 13; Matrix Metalloproteinase 8; Matrix Metalloproteinase Inhibitors; Organ Culture Techniques; Peptides; Peptidyl-Dipeptidase A; Plaque, Atherosclerotic; Quinapril; Receptor, Angiotensin, Type 1; Signal Transduction; Tetrahydroisoquinolines; Tetrazoles | 2013 |